14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $64.82 $75.66 Wednesday, 24th Apr 2024 CYTK stock ended at $66.82. This is 1.91% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.69% from a day low at $65.68 to a day high of $67.45.
90 days $61.33 $84.05
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Dec 04, 2020 $17.43 $17.50 $16.76 $17.12 796 342
Dec 03, 2020 $18.08 $18.27 $17.22 $17.46 676 182
Dec 02, 2020 $17.48 $18.19 $17.26 $18.00 1 345 903
Dec 01, 2020 $17.00 $17.94 $16.83 $17.54 907 505
Nov 30, 2020 $17.17 $17.42 $16.63 $16.80 665 097
Nov 27, 2020 $16.66 $17.23 $16.60 $17.15 455 365
Nov 25, 2020 $16.59 $16.77 $16.37 $16.59 761 832
Nov 24, 2020 $15.93 $16.89 $15.93 $16.49 1 669 870
Nov 23, 2020 $16.00 $16.22 $15.52 $16.07 1 544 162
Nov 20, 2020 $15.63 $16.25 $15.63 $15.99 889 631
Nov 19, 2020 $15.40 $16.07 $15.17 $15.84 674 728
Nov 18, 2020 $15.58 $15.90 $15.25 $15.36 915 681
Nov 17, 2020 $15.69 $15.90 $15.28 $15.51 916 368
Nov 16, 2020 $16.05 $16.43 $15.19 $15.59 1 991 495
Nov 13, 2020 $17.49 $17.94 $16.00 $16.52 2 116 197
Nov 12, 2020 $17.15 $17.70 $16.70 $17.40 1 248 565
Nov 11, 2020 $17.11 $17.19 $16.47 $17.02 858 849
Nov 10, 2020 $16.90 $17.23 $16.02 $16.90 1 077 442
Nov 09, 2020 $17.43 $17.84 $16.45 $16.86 1 267 428
Nov 06, 2020 $17.55 $17.55 $16.67 $16.94 880 687
Nov 05, 2020 $18.01 $18.39 $17.22 $17.57 1 450 636
Nov 04, 2020 $16.62 $18.30 $16.62 $18.00 967 812
Nov 03, 2020 $16.00 $16.92 $15.81 $16.72 858 103
Nov 02, 2020 $15.48 $16.00 $15.17 $15.95 841 726
Oct 30, 2020 $15.44 $15.46 $14.91 $15.37 712 362
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT